32
Participants
Start Date
June 2, 2017
Primary Completion Date
April 30, 2025
Study Completion Date
April 30, 2025
APX005M
"Dose Escalation Phase Starting Dose Level of APX005M: 0.1 mg injected directly into 1-3 tumors every 3 weeks (Weeks 0, 3, 6, and 9) for up to 4 doses.~Dose Expansion Phase Starting Dose Level of APX005M: Maximum tolerated dose from Dose Escalation Phase."
Pembrolizumab
Dose Escalation and Expansion Phase Dose of Pembrolizumab: 2 mg/kg by vein 1 time every 3 weeks (Weeks 0, 3, 6, 9, and 12). First dose of Pembrolizumab given 1-2 days before or after first dose of APX005M.
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Apexigen America, Inc.
INDUSTRY
Pyxis Oncology
UNKNOWN
M.D. Anderson Cancer Center
OTHER